Trial intelligence / Profile preview

Dexmedetomidine as an adjunct to penile block for pediatric hypospadias surgery

IRCT20130816014372N11Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of dexmedetomidine and bupivacaine in hypospadias (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Sedation score and Pain severity. Started Jun 2019; status: completed.

02

Drugs

dexmedetomidinebupivacaine
03

Conditions

hypospadias

Beyond the preview

Go deeper on IRCT20130816014372N11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130816014372N11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call